News

Infants with hearing impairment can struggle to learn language and engage fully with the world around them. But a new clinical tool – EarGenie™ – promises to give them a head start soon after birth.

The Zero Childhood Cancer Personalised Medicine Program (ZERO) is helping to improve survival outcomes for kids most at risk.

Researchers tested a drug that could help to treat Motor Neurone Disease (MND). Thanks to donors and almost $2 million in MRFF funding, the trial was run at 6 centres.

Mackenzie's Mission is a ground-breaking initiative which identifies the risk of having a child with a genetic condition.

Blood clots in leg veins and lung arteries are a significant public health problem. A new international clinical trial will test the 2 drugs currently used for treatment to compare safety and complications.

A premature infant's lungs lack a critical chemical that allows them to 'open' or 'fill'. To address this issue, the largest ever respiratory intervention trial is now underway in delivery rooms across the world.

A statement from the Australian Health Protection Principal Committee (AHPPC) on COVID-19 vaccination requirements for aged care workers.

An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 2 June 2021.

Monday 31 May is the World Health Organization’s 34th World No Tobacco Day. This day raises awareness about the dangers of tobacco use and exposure. It highlights national and global efforts to fight the tobacco epidemic and protect future generations from its harmful effects.

Expressions of interest are now open for up to 900 additional general practices to enrol in the COVID-19 vaccination program.

The Australian Government Chief Medical Officer, Professor Paul Kelly, has today declared the Greater Melbourne area a COVID-19 hotspot for the purposes of Commonwealth support for 7 days.

An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 26 May 2021.

The Medical Research Future Fund (MRFF) grant opportunities calendar is now available.

A joint statement from the Australian Technical Advisory Group on Immunisation (ATAGI) and the Thrombosis and Haemostasis society of Australia and New Zealand (THANZ) on Thrombosis with Thrombocytopenia Syndrome (TTS) and the use of COVID-19 Vaccine AstraZeneca.

The Australian Technical Advisory Group on Immunisation (ATAGI) and the Thrombosis and Haemostasis Society of Australia and New Zealand (THANZ) have released a joint statement on Thrombosis with Thrombocytopenia Syndrome (TTS) and the use of the COVID-19 Vaccine AstraZeneca.

Since COVID-19 began, people from indigenous communities around the world have been disproportionately affected by COVID-19.

An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 19 May 2021.

The Science of Immunisation: Questions and Answers guide has been updated. The guide looks at the benefits and safety of vaccines, what is in vaccines and what the future holds for vaccination.

An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 12 May 2021.

The Australian Government has announced an investment of $2.6 billion over the next four years for the Medical Research Future Fund (MRFF) in the 2021-22 Federal Budget. This continued investment will help drive innovation, improve health outcomes, and create jobs.

Health Budget 2021–22 information is now available.

A $17.7 billion reform package will provide higher quality and safer care for senior Australians.

The Australian Government is investing $2.3 billion in the National Mental Health and Suicide Prevention Plan – the largest Commonwealth mental health investment in Australia’s history.

Find accurate, evidence-based answers to questions about COVID-19 vaccines, including whether you should take blood thinning medication before having the AstraZeneca vaccine.

An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 4 May 2021